Skip to main content
SpringerLink
Log in

Epidemiology of Progressive Multiple Sclerosis

  • Chapter
  • First Online:
Progressive Multiple Sclerosis

  • 1842 Accesses

Abstract

The recognition that the course of MS could show striking variation between patients was made in some of the earliest descriptions of the disease. Whereas the majority of patients follow an initial phase of disease characterized by bouts of relapsing neurological dysfunction, or bout onset MS (BOMS), occurring at unpredictable intervals with variable recovery, a minority of patients exhibit a gradual evolution of symptoms commonly related to spinal cord dysfunction but occasionally cerebellar or cognitive in nature. Despite heated debate and considerable investment in investigative studies, it remains unclear whether patients with primary progressive MS (PPMS) represent a distinct disorder or whether a progressive phase of disease is an inevitable consequence of the evolving pathology of disease, and in particular a reflection of gradual axonal degeneration whose origins lie within a dominant early phase of inflammation and demyelination. The debate is complicated by the fact that, despite recent advances in disease classification, there remains no diagnostic test for MS, let alone its clinical subgroups, and that diagnosis is constructed from probabilistic models of accumulated clinical and paraclinical data. Because of this and recognition of distinct immunological or genetic disorders previously considered to be under the rubric of prior MS disease classifications, it seems likely that additional discrete diseases or disease subgroups will emerge over time, but whether these will include forms of progressive disease remains unclear. In the meantime, the epidemiological data available addressing the progressive phases of disease is wide and varied and able to shed some light on these issues.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Andersson PB, et al. Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability. Arch Neurol. 1999;56(9):1138–42.

    Article  PubMed  CAS  Google Scholar 

  2. Leray E, et al. Evidence for a two-stage disability progression in multiple sclerosis. Brain. 2010;133(Pt 7):1900–13.

    Article  PubMed  Google Scholar 

  3. Koch M, De Keyser J, Tremlett H. Timing of birth and disease progression in multiple sclerosis. Mult Scler. 2008;14(6):793–8.

    Article  PubMed  CAS  Google Scholar 

  4. Debouverie M, et al. Multiple sclerosis with a progressive course from onset in Lorraine-Eastern France. J Neurol. 2007;254(10):1370–5.

    Article  PubMed  CAS  Google Scholar 

  5. Cottrell DA. The natural history of multiple sclerosis: a geographically based study 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain. 1999;122(Pt 4):625–39.

    Article  PubMed  Google Scholar 

  6. Confavreux C, et al. Relapses and progression of disability in multiple sclerosis. N Engl J Med. 2000;343(20):1430–8.

    Article  PubMed  CAS  Google Scholar 

  7. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain. 1993;116(Pt 1):117–34.

    Article  PubMed  Google Scholar 

  8. Tremlett H, Paty D, Devonshire V. Disability progression in multiple sclerosis is slower than previously reported. Neurology. 2006;66(2):172–7.

    Article  PubMed  Google Scholar 

  9. Confavreux C, Aimard G, Devic M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain. 1980;103(2):281–300.

    Article  PubMed  CAS  Google Scholar 

  10. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996;46(4):907–11.

    Article  PubMed  CAS  Google Scholar 

  11. Minderhoud JM, van der Hoeven JH, Prange AJ. Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study. Acta Neurol Scand. 1988;78(1):10–5.

    Article  PubMed  CAS  Google Scholar 

  12. Koch M, et al. Progression in multiple sclerosis: further evidence of an age dependent process. J Neurol Sci. 2007;255(1–2):35–41.

    Article  PubMed  CAS  Google Scholar 

  13. Weinshenker BG, et al. The natural history of multiple sclerosis: a geographically based study I. Clinical course and disability. Brain. 1989;112(Pt 1):133–46.

    Article  PubMed  Google Scholar 

  14. Cossburn M, et al. Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis. Mult Scler. 2012;18(1):45–54.

    Article  PubMed  CAS  Google Scholar 

  15. McDonnell GV, Hawkins SA. Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK. J Neurol Neurosurg Psychiatry. 1998;64(4):451–4.

    Article  PubMed  CAS  Google Scholar 

  16. Simone IL, et al. Course and prognosis in early-onset MS: comparison with adult-onset forms. Neurology. 2002;59(12):1922–8.

    Article  PubMed  CAS  Google Scholar 

  17. Kremenchutzky M, et al. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain. 2006;129(Pt 3):584–94.

    Article  PubMed  CAS  Google Scholar 

  18. Tremlett H, Paty D, Devonshire V. The natural history of primary progressive MS in British Columbia, Canada. Neurology. 2005;65(12):1919–23.

    Article  PubMed  Google Scholar 

  19. Tremlett H, Zhao Y, Devonshire V. Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities. J Neurol. 2009;256(3):374–81.

    Article  PubMed  Google Scholar 

  20. Boiko A, et al. Early onset multiple sclerosis: a longitudinal study. Neurology. 2002;59(7):1006–10.

    Article  PubMed  CAS  Google Scholar 

  21. Ruggieri M, et al. Multiple sclerosis in children under 6 years of age. Neurology. 1999;53(3):478–84.

    Article  PubMed  CAS  Google Scholar 

  22. Riise T, et al. Early prognostic factors for disability in multiple sclerosis, a European multicenter study. Acta Neurol Scand. 1992;85(3):212–8.

    Article  PubMed  CAS  Google Scholar 

  23. Stankoff B, et al. Age at onset determines the occurrence of the progressive phase of multiple sclerosis. Neurology. 2007;68(10):779–81.

    Article  PubMed  CAS  Google Scholar 

  24. Kremenchutzky M. The natural history of multiple sclerosis: a geographically based study 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. Brain. 1999;122(Pt 10):1941–50.

    Article  PubMed  Google Scholar 

  25. Koch M, et al. The natural history of primary progressive multiple sclerosis. Neurology. 2009;73(23):1996–2002.

    Article  PubMed  Google Scholar 

  26. Koch M, et al. The natural history of secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry. 2010;81(9):1039–43.

    Article  PubMed  Google Scholar 

  27. Debouverie M, et al. Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients. Mult Scler. 2009;15(2):251–7.

    Article  PubMed  CAS  Google Scholar 

  28. Grytten Torkildsen N. Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway. Mult Scler. 2008;14(9):1191–8.

    Article  PubMed  CAS  Google Scholar 

  29. Pekmezovic T, et al. Survival of multiple sclerosis patients in the Belgrade population. Neuroepidemiology. 2002;21(5):235–40.

    Article  PubMed  Google Scholar 

  30. Phadke JG, Downie AW. Epidemiology of multiple sclerosis in the north-east (Grampian region) of Scotland – an update. J Epidemiol Community Health. 1987;41(1):5–13.

    Article  PubMed  CAS  Google Scholar 

  31. Levic ZM, et al. Prognostic factors for survival in multiple sclerosis. Mult Scler. 1999;5(3):171–8.

    PubMed  CAS  Google Scholar 

  32. Midgard R, et al. Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in More and Romsdal, Norway. J Neurol Neurosurg Psychiatry. 1995;58(4):417–21.

    Article  PubMed  CAS  Google Scholar 

  33. Riise T, et al. Prognostic factors for life expectancy in multiple sclerosis analysed by Cox-models. J Clin Epidemiol. 1988;41(10):1031–6.

    Article  PubMed  CAS  Google Scholar 

  34. Poser S, et al. Prognostic indicators in multiple sclerosis. Acta Neurol Scand. 1986;74(5):387–92.

    Article  PubMed  CAS  Google Scholar 

  35. Sumelahti ML, et al. Survival of multiple sclerosis in Finland between 1964 and 1993. Mult Scler. 2002;8(4):350–5.

    Article  PubMed  CAS  Google Scholar 

  36. Miller DH, Hornabrook RW, Purdie G. The natural history of multiple sclerosis: a regional study with some longitudinal data. J Neurol Neurosurg Psychiatry. 1992;55(5):341–6.

    Article  PubMed  CAS  Google Scholar 

  37. Trojano M, et al. Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. J Neurol Neurosurg Psychiatry. 1995;58(3):300–6.

    Article  PubMed  CAS  Google Scholar 

  38. Kantarci O. Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG). Neurology. 1998;51(3):765–72.

    Article  PubMed  CAS  Google Scholar 

  39. Weinshenker BG. The natural history of multiple sclerosis: a geographically based study 3. Multivariate analysis of predictive factors and models of outcome. Brain. 1991;114(Pt 2):1045–56.

    Article  PubMed  Google Scholar 

  40. Amato MP, et al. A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials. J Neurol Sci. 1999;168(2):96–106.

    Article  PubMed  CAS  Google Scholar 

  41. Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain. 2003;126(Pt 4):770–82.

    Article  PubMed  Google Scholar 

  42. Myhr KM, et al. Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension. Mult Scler. 2001;7(1):59–65.

    PubMed  CAS  Google Scholar 

  43. Ebers GC. The natural history of multiple sclerosis. Neurol Sci. 2000;21(4 Suppl 2):S815–7.

    Article  PubMed  CAS  Google Scholar 

  44. Khaleeli Z, et al. Predicting progression in primary progressive multiple sclerosis: a 10-year multicenter study. Ann Neurol. 2008;63(6):790–3.

    Article  PubMed  Google Scholar 

  45. Ferreira Vasconcelos CC. Differences in the progression of primary progressive multiple sclerosis in Brazilians of African descent versus white Brazilian patients. Mult Scler. 2010;16(5):597–603.

    Article  PubMed  Google Scholar 

  46. Vukusic S, Confavreux C. Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis. J Neurol Sci. 2003;206(2):135–7.

    Article  PubMed  Google Scholar 

  47. Confavreux C, Vukusic S. Natural history of multiple sclerosis: a unifying concept. Brain. 2006;129(Pt 3):606–16.

    Article  PubMed  Google Scholar 

  48. Binquet C, et al. The prognostic value of initial relapses on the evolution of disability in patients with relapsing-remitting multiple sclerosis. Neuroepidemiology. 2006;27(1):45–54.

    Article  PubMed  CAS  Google Scholar 

  49. Scalfari A, et al. The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability. Brain. 2010;133(Pt 7):1914–29.

    Article  PubMed  Google Scholar 

  50. Tremlett H, Yinshan Z, Devonshire V. Natural history of secondary-progressive multiple sclerosis. Mult Scler. 2008;14(3):314–24.

    Article  PubMed  Google Scholar 

  51. Bergamaschi R, et al. Disability and mortality in a cohort of multiple sclerosis patients: a reappraisal. Neuroepidemiology. 2005;25(1):15–8.

    Article  PubMed  Google Scholar 

  52. Eriksson M, Andersen O, Runmarker B. Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis. Mult Scler. 2003;9(3):260–74.

    Article  PubMed  Google Scholar 

  53. Thompson AJ, et al. Primary progressive multiple sclerosis. Brain. 1997;120(Pt 6):1085–96.

    Article  PubMed  Google Scholar 

  54. Ebers GC. Natural history of primary progressive multiple sclerosis. Mult Scler. 2004;10 Suppl 1:S8–13; discussion S13–5.

    Article  PubMed  Google Scholar 

  55. Trojano M, et al. Age-related disability in multiple sclerosis. Ann Neurol. 2002;51(4):475–80.

    Article  PubMed  Google Scholar 

  56. Confavreux C, Vukusic S. Age at disability milestones in multiple sclerosis. Brain. 2006;129(Pt 3):595–605.

    Article  PubMed  Google Scholar 

  57. Koch M, et al. Progression in familial and nonfamilial MS. Mult Scler. 2008;14(3):300–6.

    Article  PubMed  Google Scholar 

  58. Koch M, et al. Factors associated with the risk of secondary progression in multiple sclerosis. Mult Scler. 2008;14(6):799–803.

    Article  PubMed  CAS  Google Scholar 

  59. Bergamaschi R, et al. Predicting secondary progression in relapsing-remitting multiple sclerosis: a Bayesian analysis. J Neurol Sci. 2001;189(1–2):13–21.

    Article  PubMed  CAS  Google Scholar 

  60. Tremlett H, et al. Impact of multiple sclerosis relapses on progression diminishes with time. Neurology. 2009;73(20):1616–23.

    Article  PubMed  CAS  Google Scholar 

  61. Ebers GC, et al. The natural history of multiple sclerosis: a geographically based study 8: familial multiple sclerosis. Brain. 2000;123(Pt 3):641–9.

    Article  PubMed  Google Scholar 

  62. Koch M, et al. Disease onset in familial and sporadic primary progressive multiple sclerosis. Mult Scler. 2010;16(6):694–700.

    Article  PubMed  CAS  Google Scholar 

  63. Robertson NP, et al. Clinical concordance in sibling pairs with multiple sclerosis. Neurology. 1996;47(2):347–52.

    Article  PubMed  CAS  Google Scholar 

  64. Hensiek AE, et al. Familial effects on the clinical course of multiple sclerosis. Neurology. 2007;68(5):376–83.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Helen Durham Neuro-inflammatory Centre, Institute of Psychological Medicine and Clinical Neuroscience, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN, UK

    Neil Robertson M.B.B.S., M.D.

  2. Department of Neurology, Morriston Hospital, Swansea, UK

    Claire Hirst MB BCh, M.D.

Authors
  1. Neil Robertson M.B.B.S., M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claire Hirst MB BCh, M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Neil Robertson M.B.B.S., M.D. .

Editor information

Editors and Affiliations

  1. , Department of Neurology, Frenchay Hospital, Frenchay Park Road, Bristol, BS16 1LE, United Kingdom

    Alastair Wilkins

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Robertson, N., Hirst, C. (2013). Epidemiology of Progressive Multiple Sclerosis. In: Wilkins, A. (eds) Progressive Multiple Sclerosis. Springer, London. https://doi.org/10.1007/978-1-4471-2395-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2395-8_3

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2394-1

  • Online ISBN: 978-1-4471-2395-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation